+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

HMGB1 and RAGE in inflammation and cancer

HMGB1 and RAGE in inflammation and cancer

Annual Review of Immunology 28: 367-388

The immune system has evolved to respond not only to pathogens, but also to signals released from dying cells. Cell death through necrosis induces inflammation, whereas apoptotic cell death provides an important signal for tolerance induction. High mobility group box 1 (HMGB1) is a DNA-binding nuclear protein, released actively following cytokine stimulation as well as passively during cell death; it is the prototypic damage-associated molecular pattern (DAMP) molecule and has been implicated in several inflammatory disorders. HMGB1 can associate with other molecules, including TLR ligands and cytokines, and activates cells through the differential engagement of multiple surface receptors including TLR2, TLR4, and RAGE. RAGE is a multiligand receptor that binds structurally diverse molecules, including not only HMGB1, but also S100 family members and amyloid-beta. RAGE activation has been implicated in sterile inflammation as well as in cancer, diabetes, and Alzheimer's disease. While HMGB1 through interactions with TLRs may also be important, this review focuses on the role of the HMGB1-RAGE axis in inflammation and cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 053468204

Download citation: RISBibTeXText

PMID: 20192808

DOI: 10.1146/annurev.immunol.021908.132603

Related references

Involvement of HMGB1 and RAGE in IL-1β-induced gingival inflammation. Archives of Oral Biology 57(1): 73-80, 2012

HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opinion on Therapeutic Targets 15(8): 1023-1035, 2011

Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. American Journal of Pathology 175(3): 958-975, 2009

HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis. Experimental Neurology 271: 189-197, 2015

HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients. Journal of Translational Medicine 13(): 310-310, 2016

Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 120(5): 277-281, 2013

TREM-1, HMGB1 and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis. Plos One 11(10): E0165492-E0165492, 2016

The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway. Molecular and Cellular Biochemistry 380(1-2): 249-257, 2014

Helicobacter pylori Activates HMGB1 Expression and Recruits RAGE into Lipid Rafts to Promote Inflammation in Gastric Epithelial Cells. Frontiers in Immunology 7: 341-341, 2016

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. Journal of Translational Medicine 7: 17-17, 2009

Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. Plos One 8(9): E76039-E76039, 2014

Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer. American Journal of Cancer Research 4(4): 369-377, 2014

Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression. Neuroscience Letters 471(3): 152-156, 2010

Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome. Shock 43(2): 109-116, 2015

HMGB1 modulates Lewis cell autophagy and promotes cell survival via RAGE-HMGB1-Erk1/2 positive feedback during nutrient depletion. Immunobiology 220(5): 539-544, 2016